MediaPharma intends to advance its proprietary products portfolio to initial clinical safety and efficacy endpoints, then form strategic partnerships with companies that have the necessary commercialization infrastructures to best capture value.

However, we are interested in forging partnership alliances at all development stages should such arrangements facilitate the rapid development of the product.